铁矿石反浮选用的阳离子活性药剂的选择

铁矿石阳离子反浮选是铁精矿精选最有前途的方法之一。这种方法在苏联各选矿企业中难以投入使用,在很大程度上是因为缺少有效而且毒性小的阳离子捕收剂。目前已研制了大量的阳离子表面活性剂,然而,在选择矿石浮选捕收剂时,主要用试验方法。

小分子表面活性剂在原油脱水中的应用

西北油田二号联合站属超重质稠油片区,为了提高作业采收率,大量使用三次采油技术,同时掺稀组分、油水比的变化以及其他化学物理环境变化等的综合因素,给重质原油破乳带来巨大的困难。原油中的重质成分、固体颗粒杂质含量的增加、钻采油化学药剂的大量加注等导致采出液稳定性大幅提升,对破乳剂性能提出了更高的要求。作者引入小分子双亲表面活性剂,通过小分子的先行渗透,一定程度上改善了乳状液界面状态,提升了破乳剂的脱水性能,提高了现场运行效率,降低了药剂总体消耗量。

腐烂茎线虫对不同外源物的敏感性测定

采用药剂浸渍法测定腐烂茎线虫对6种不同外源物的敏感性。结果显示,将50%氯溴异氰尿酸可溶粉剂稀释成2400倍液处理24、48和144 h后对腐烂茎线虫仍有较高活性,各处理中均无线虫复苏现象,表现出稳定的防控效果。而将25%噻虫嗪水分散粒剂稀释成400~600倍液处理48 h后对腐烂茎线虫表现出较好的防效,随着稀释倍数增加,处理液浓度降低,线虫敏感性降低。枯草芽孢杆菌对线虫防控效果较好,稀释成400~600倍液处理144 h,对线虫的击倒率达80%以上;但在个别处理中也存在线虫复苏现象。试验中也发现,将槟榔粉稀释成400~600倍液后表现出较好的击倒效果,可作为固体药剂的填充材料用于线虫防控。腐烂茎线虫对辛硫磷敏感性并不高,室内测定药效不理想。

Transdermal Drug Delivery by Electroporation： The Effects of Surfactants on Pathway Lifetime and Drug Transport

Electroporation creates aqueous pathways by short high-voltage pulses resulting in a transient perme- abilization of stratum corneum and an increase in the transdermal delivery rate.However the aqueous pathways will reseal after pulsing,which leads to the rapid drop of transdermal flux.In the present study,the surfactants were added to the donor solution to hinder the shrinkage and resealing of the electropore,and to prolong the lifetime of the aqueous pathways with the consideration that the surfactants could reduce the surface energy of the electropore. These effects of surfactants were demonstrated by the dynamic electrical resistance of the skin and the fluorescent imaging of the local transport regions.Piroxicam(PIX)was transported percutaneously in the presence of surfac- tants in vitro.Owing to the longer lifetime of aqueous pathways,together with the promotion of PIX availability at the barrier exterior and the improvement in the partition of PIX into the aqueous pathways,the presence of surfac- tants led to a remarkable increase in the transdermal delivery rate during electroporation and a significant growth of the accumulative transdermal amount of PIX.

Antioxidant therapy for chronic hepatitis C after failure of interferon:Results of phase Ⅱ randomized,double-blind placebo controlled clinical trial

AIM： TO assess the safety and efficacy of antioxidant therapy for patients with chronic hepatitis C virus （HCV） infection.METHODS： One hundred chronic HCV infection patients failed in interferon treatment were enrolled and randomly assigned to receive combined intravenous and oral antioxidants or placebo, or oral treatment alone, Primary end points were liver enzymes, HCV-RNA levels and histology.RESULTS： Combined oral and intravenous antioxidant therapy was associated with a significant decline in ALT levels in 52% of patients who received antioxidant therapy vs 20% of patients who received placebo （P = 0.05）. Histology activity index （HAI） score at the end of treatment was reduced in 48% of patients who received antioxidant therapy vs 26% of patients who received placebo （P = 0.21）. HCV-RNA levels decreased by l-log or more in 28% of patients who received antioxidant therapy vs 12% who received placebo （P = NS）. In part 11 of the trial, oral administration of antioxidants was not associated with significant alterations in any of the end points.CONCLUSION： Antioxidant therapy has a mild beneficial effect on the inflammatory response of chronic HCV infection patients who are non-responders to interferon. Combined antiviral and antioxidant therapy may be beneficial for these patients.

Effects of Shenmai Injection on Blood SOD Activity and MDA Level in Senile Patients with Coronary Heart Disease

In order to approach the effects of Shenmai Injection on SOD activity and MDA level in the senile patients with coronary heart disease, 48 cases, who had stenosis of over 70% in more than one branches of the coronary arteries, were assigned randomly into a treatment group (given Shenmai Injection plus the routine treatment) and a control group (given the routine treatment only). The superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were determined before treatment and at the end of a 3-week treatment. The results showed that in the treatment group, the SOD activity was significantly increased (P＜0.05) and the MDA level markedly decreased (P＜0.01) in the treatment group. It can be concluded that Shenmai Injection may enhance the antioxidant ability of the senile patients with coronary heart disease.

Selenium Distribution Pattern, Antineoplastic and Immunostimulatory Activities of a Novel Organoselenium Compound Eb

Aim To study the distribution pattern, antineoplastic activity and immunocompetence of a novel organoselenium compound Eb and investigate its in vivo antineoplastic potential. Methods Eb was administered to Kunming mice (dosage, 0.1 g·kg^(-1)·d^(-1)) intragastrically for 7 successive days. The contents of selenium in heart, liver, spleen, kidneys, lungs, stomach, brain, muscle, and bone were determined by fluorometric method on the eighth day. MTT assay was used to study tumor growth inhibition of Eb in vitro, and lymphocyte transformation, hemolysin formation and phagocytosis assay were used to study its immunocompetence. Results After 7 days′ administration of Eb, the tissue contents of sele-(nium) in liver, spleen, lungs, kidneys, and bone of mice increased, especially those in liver and spleen increased significan-tly, compared with controls; but no significant changes of such contents were found in muscle, heart, brain, and stomach. Eb demonstrated inhibitory effects on human Bel-7402, BGC-823, and Calu-3 cancer cell lines in vitro. Eb also showed ability to enhance lymphocyte transformation and serum hemolysin formation in vitro and increase the phagocytosis of macrophages. Conclusion The validated antitumor and immunostimulatory activities of Eb suggest a hypothesis that Eb may behave as a biological response modifier when used as an antitumor agent. Eb is worthy of further study in developing a new antineoplastic and immunity enhancing agent in the light of its antitumor activity, immunocompetence and specific distribution in liver, lungs, kidneys, bone, and spleen.

稀释农药的科学方珐

正确、合理、科学的农药稀释方法是节约资金、防止浪费、保证药效的一个重要条件。现对各种剂型的农药的稀释方法介绍如下，以便农民朋友在稀释农药时能够正确采用。

Investigation of the Mutagenic Potential of Immunomodulator Arglabin Native in Tablets in the Ames Test

The mandatory preclinical safety evaluation is an essential prerequisite to obtain the qualitative and effective medicines. Due to the fact that drugs may reveal genotoxic properties, the investigation of their mutagenic activity is an obligatory part of the preclinical drug safety program. The aim of the research is to study mutagenic properties of a new original immunomodulator Arglabin native in tablets in the induced test of gene mutations （the Ames test） on Salmonella typhimurium strains. Materials and methods： Four strains of S. typhimurium TA98, TA100, TA1535, and TA1537 were used to assess the mutagenicity in the Ames test. Results and conclusions： No statistically reliable dose-dependent increase in the number of revertant colonies of Salmonella typhimurium has been observed in the presence of the given drug within the investigated dose ranges from 5.0 to 100.0 μg/mL for strains TA100 and TA1535, and from 5.0 to 250 μg/mL for strains TA98 and TA1537 against the baseline of spantaneous mutations. Arglabin native in tablets does not reveal a mutagenic activity within the studied dose ranges on Salmonella typhimurium strains TA98, TA100, TA1535, TA1537.

In Vivo Anti-Inflammatory Assessment of Quillaja saponaria Mol. Extracts

Aqueous extracts from the native Chilean Quillaja saponaria tree are used orally and topically to treat lung inflammatory problems and toothache. This study aimed to corroborate their presumed anti-inflammatory activity, identify their active ingredients and validate their use. The topical anti-inflammatory activity of a commercial partially purified Quillaja saponin aqueous extract （Ultra Dry 100Q, UD）, the crude acid hydrolysate （H-100Q） of this material, its two most abundant sapogenins QA （quillaic acid） and PA （phytolaccagenic acid）, and two formulations containing QA were subjected to topical assays for the inhibition ofmurine ear inflammation elicited by AA （arachidonic acid） or TPA （phorbol ester）. The dose-dependent anti-inflammatory activity of QA was confirmed in both AA （maximal effect 92.1%） and TPA （maximal effect 62.2%） assays, and PA showed significant anti-inflammatory activity against AA （46.5%）. Two dermo pharmaceutical formulations containing 8% w/v QA as the active ingredient--a cream and a gel--also exhibited significant anti-inflammatory effects in the TPA （50.8%） and AA （39.5%） assays.

Eggs as a Very Promising Source of Biomedical and Nutraceutical Preparations： A Review

It is generally accepted that eggs besides being a source of everyday diet, can also be used as raw material for special food, nutraceutical, pharmaceutical and cosmetic production. The biological activity of the majority of substances presented in egg matter is related to their anti-microbial and anti-cancer properties and their immunogenic features as well. Due to the use of new generation of feed additives and techniques of immunisation of hens, the chemical composition and biological features of eggs may be modified and enriched with desired components, like n-3 fatty acids （alpha-linolenic acid （ALA）, docosahexaenoic acid （DHA） phospholipids）, vitamins, microelements. Egg material may also be used for the production of new biopreparations for the prophylaxis of various civilisation diseases, such as heart and cardiovascular diseases, cancers, neurogenerative disorders, metabolic bone diseases etc.. New progress in egg science allowed to discover new bioactive substances, like monomeric and dimeric cystatin and yolkin. It is necessary to develop efficient methods of isolation of biologically active substances contained in eggs, which would make it possible to produce new generation of diet supplements and biomedical products. It seems that new generation of eggs could be the best source for production of natural, high value nutraceutical supplements of diet, and also biomedical and biocosmetic preparations.

Antihymolytic and Antioxidant Effects of Medicinal Plant Capparis spinosa L.

Capparis spinosa L. is a traditionally used plant in Algerian folk medicine to treat asthma, rheumatism and other free radicals related disorders such inflammatory. The present study was designated to study the antioxidant activity of aerial and root parts of Capparis spinosa L.. Total polyphenol content was determined, after extraction with solvents in five subfractions; methanol （CE）, Hexan （HE） chloroform （CHE）, ethyl acetate （EAE） and aqueous extracts （AE）, employing the ＂Prussian blue assay＂. The results showed that EAE containing the highest concentration of phenolic compounds and Flavonoids followed by those of CHE of aerial and root parts, repectively. The antioxidant protective effects of extracts were determined by measuring the erythrocyte membrane resistance to free radical-induced. The results demonstrated that all the extracts exhibited a protective effect against t-BHP induced oxidative damages in human erythrocytes, the most potents wer CEs and CHEs with 86.55%, 85.81%, 74.59%, and 68.70%, for aerial and root parts, respectively, which were more effective than used standards： Quercetin （65.46%） and rutin （59.62%）. In order to more clarify the previous antioxidants activity of the extracts through other mechanisms, the iron chelating ability assays were realized. The results showed that the iron chelating ability of Aerial and root extracts were very considerable; the CE showed an excellent chelating with ICs0 of 0.197 ± 0.031 μM/quercetin equivalent, higher than that used standard EDTA, with approximately 0.34 folds. These results show that Capparis spinosa L. extracts have strong anti-oxidant effects and may have some clinical benefits.

Enhancement of transdermal delivery of docetaxel by surfactant-ethanolic liposomes

One major problem encountered in transdermal drug delivery is the low permeability of drugs through the skin barrier. In the present study, we developed a surfactant-ethanolic liposomal system to improve the transdermal delivery of docetaxel （DTX）, a model drug for high molecular weight and poorly water-soluble drugs. Surfactant-ethanolic liposomes （SEL） were composed of phospholipids, ethanol, sodium cholate, DTX and PBS which were prepared by thin film dispersion method. The developed formulations were characterized by determining the vesicle shape and surface morphology, size and size distribution, entrapment efficiency and drug loading capacity. The effects of the developed formulations on the permeation of DTX across rat skin in vitro were investigated using the modified Franz diffusion cell under both occlusive and non-occlusive application condi- tions. The DTX SELs with optimum composition （phospholipid-surfactant, 85：15, w/w） provided a significantly higher steadystate amount of flux and cumulative permeation, compared to the tranditional liposomes, surfactant liposomes and ethanolic liposomes. The optimal SELs exhibited stable vesicle size, morphology and drug loading capacity. Our results indicated that SELs were promising carriers to enhance the transdermal delivery of DTX.

STUDIES ON CULTIVAR-INDUCED CHANGES IN INSECTICIDE SUSCEPTIBILITY AND ITS RELATED ENZYME ACTIVITIES OF THE WHITE BACKED PLANTHOPPER, SOGATELLA FURCIFERA (HORVTH) (HOMOPTERA:DELPHACIDAE)

The susceptibility of Sogatella furcifera female adults on N22 to malathion increased as feeding time prolonged, while the day change of susceptibility to isoprocarb showed a inverse tendency. The activities of esterase and carboxylesterase were induced significantly after on N22 for one day, and then declined. The non susceptible level of adults to insecticides and enzyme activities seemed to be heightened after feeding on ASD7, a variety resistant to Nilaparvata lugens. The total phenol content in rice leaf sheath was the highest in N22, and could be regarded as one of the factors, which caused chages in susceptibility of S. furcifera to insecticide after feeding different rice varieties. It was recommended that suitable insecticides and planthopper resistant varieties should be coordinately used in practice so that they contribute more effects respectively.

Effects of Rong Shuan capsule, Xue Zhi Kang capsule, Xin Yuan capsule and Songling Xue Mai Kang capsule on the pharmacokinetics of clopidogrel active metabolite in rats

In the present study, we aimed to examine the effects of Rong Shuan capsule, Xue Zhi Kang capsule, Xin Yuan capsule and Songling Xue Mai Kang capsule on the pharmacokinetics of clopidogrel active metabolite（CAM）. The traditional Chinese medicines（TCMs） Rong Shuan capsule, Xue Zhi Kang capsule, Xin Yuan capsule and Songling Xue Mai Kang capsule are widely used to treat cardiovascular disease in China. They are often prescribed in combination with clopidogrel, a common anti-platelet Western drug. We investigated the influence of the four TCMs on CAM pharmacokinetics following administration at human dose in rats. Pharmacokinetic parameters were determined following oral（PO） administration of clopidogrel（7.5 mg/kg） with or without Rong Shuan capsule（75 mg/kg, PO）, Xue Zhi Kang capsule（60 mg/kg, PO）, Xin Yuan capsule（120 mg/kg, PO）, or Songling Xue Mai Kang capsule（150 mg/kg, PO）. Compared with the animals in the control group, Xue Zhi Kang capsule significantly decreased the area under the plasma concentration-time curve（AUC_（0-t）） of the CAM derivative by 25.4%. However, the t1/2 and Vz/F of CAM derivative were significantly increased by 43.6% and 70.7%, respectively. It was also observed that the pharmacokinetic parameters were altered in groups pretreated with Rong shuan capsule, Xin yuan capsule or Songling Xue mai kang capsule compared with the control group, but not significant. This study indicated that Xue Zhi Kang capsule had an effect on the formation and metabolism of CAM. Therefore, in the beginning of co-administration of Xue Zhi Kang capsule and clopidogrel, the anti-platelet efficacy might be compromised because of the decreased formation of CAM. Otherwise, long-time co-administration might lead to side effects by the prolongation of the t1/2 and Vz/F increase of CAM.